Phase 3 Readout~month
Phase 3 Topline: An International Pilot Study of Chemotherapy and Tyrosine Kinase Inhibitors With Blinatumomab in Pat
- Company
- Cosmos Health Inc. (COSM)
- Drug
- chemotherapy
- Indication
- B Acute Lymphoblastic Leukemia
Other upcoming events for COSM
Phase 3 ReadoutPhase 3 Topline: A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patient
Phase 3 ReadoutPhase 3 Topline: A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy With Immuno-oncology
Patent ExpiryPatent/Exclusivity Expiry: VYXEOS
Patent ExpiryPatent/Exclusivity Expiry: KHAPZORY
Patent ExpiryPatent/Exclusivity Expiry: IMKELDI
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.